Natural compounds

Preliminary Pre-Clinical Evaluation of a Molecule With Anti-Seizure Effects

BICS01 Epilepsy ASD molecule

Despite the availability of around 30 anti-seizure drugs, drug-resistant epilepsy remains a significant clinical and societal burden. We report the first promising result of a new candidate BICS01.

Planegg / Martinsried (Germany) – January 7, 2022 – Bicoll, an expert in synthesizing new and relevant small molecules as starting points for accelerated drug development, worked together with its partners at the University College London, FutureNeuro, and Royal College of Surgeons to publish data for a promising anti-seizure drug candidate BICS01 in Frontiers in Neurology.

Read more

12th Wartburg Symposium on Flavor Chemistry & Biology

Eisenach, Germany, May 21 – 24, 2019 Cutting-edge research in taste and smell returns once more to the beautiful “Hotel on the Wartburg” in Eisenach, Germany. Since its inception in 1978, the Wartburg Symposium on Flavor Chemistry & Biology has …

Read more

Bicoll Natural Compounds Library: Bio-Europe 2015

Dr. Kai Lamottke joined BIO-Europe 2015 Munich, Germany: Introducing Bicoll Natural Compounds Library. This event is Europe’s largest life science partnering conference with powerful opportunities to network with the right partners and bring together hundreds of the world’s most innovative …

Read more

Join us at Biotechgate Partnering February 7th - 11thBiotechgate Partnering
+ +